Medicine News and Research

RSS

New Zealand life science and health IT companies to showcase their products in San Francisco

New Zealand is well known for its wines and stunning scenery, but the country is also a great source of innovation in the life sciences. A delegation of New Zealand life sciences companies who have reached key stages in their development are joining the throngs of international therapeutics, medical device and health IT companies in San Francisco, January 9 - 12 to showcase their products and capabilities to potential corporate partners and investors.

7 Jan 2012

Proposal to tie likelihood of sleep apnea to body mass index

The first lawsuit against a trucking company acknowledging that sleep apnea played a role in a highway death reached a settlement last week. A Texas family was awarded over $3 million dollars after a driver rear-ended John Lindsay's vehicle on a Texas interstate in May of 2010. Evidence showed that the driver had refused to treat his previously diagnosed sleep apnea and the company did not ensure follow up care was provided.

7 Jan 2012

Winners of JHM competition to receive John G. Rangos Medal of Honor in Creative Thinking

Five Johns Hopkins students have been selected as finalists in a competition to find new ways to cure metastatic cancer. The five, whose ideas were chosen from among 44 presentations, will compete on January 13, 2012, from 3 p.m. to 5 p.m., for the top prize of $20,000 and a chance to pursue their research proposals.

7 Jan 2012

OCF to offer free oral cancer screenings in April 2012

Did you know that the fastest growing segment of the oral cancer community is young, healthy non-smokers? It's shocking but true. Exposure to the HPV-16 virus, the most common sexually transmitted infection, is now the leading cause of oral cancers in the U.S. There is little that can be done to stop this virus from spreading. Our only hope to save lives is through increased professional involvement and public awareness to generate early discovery of the disease process.

7 Jan 2012

Major tobacco company manipulates data on effects of additives in cigarettes

A new UCSF analysis of tobacco industry documents shows that Philip Morris USA manipulated data on the effects of additives in cigarettes, including menthol, obscuring actual toxicity levels and increasing the risk of heart, cancer and other diseases for smokers.

7 Jan 2012

Smokeless tobacco products in India associated with increased risk of oral cancer

The 2nd International Conference on the Frontiers in Prevention, Diagnosis & Therapy of Cancer was held on 7th Jan. 2012 at Allahabad, India and looked at the relationship of oral cancer with tobacco habits. Various innovations in oral cancer diagnosis, therapy and tobacco usage were discussed by experts from around the world.

7 Jan 2012

CMS selects UofL geriatrician for Innovation Advisors Program

Christian Davis Furman, M.D., M.S.P.H., vice chair for geriatric medicine in the Department of Family and Geriatric Medicine at the University of Louisville, has been selected for the Centers for Medicare and Medicaid Services' (CMS) Innovation Advisors Program. She is the only Kentuckian among the 73 individuals from 27 states and the District of Columbia selected to participate.

7 Jan 2012

HHS Secretary Sebelius discusses agency's global health strategy at KFF/HHS briefing

Speaking at a briefing on Thursday sponsored by the Kaiser Family Foundation (KFF) and the Department of Health and Human Services (HHS) to explore the department's role in global health and its Global Health Strategy, HHS Secretary Kathleen Sebelius discussed the agency's "first global health strategy ..., which explains the Obama administration's priorities during an era of budget-cutting," CQ HealthBeat reports.

7 Jan 2012

Drinking red wine in moderation may reduce risk of breast cancer

Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.

7 Jan 2012

Annual prostate cancer testing does not reduce mortality among men

Men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had no evidence of a mortality benefit compared to a control group of men undergoing usual care, according to a study published online Jan. 6 in the Journal of the National Cancer Institute.

7 Jan 2012

SPIE to honor CCNY professor with Britton Chance Biomedical Optics Award

A scientific innovator from The City College of New York (CCNY) whose research unites the divergent fields of medicine, biology and high-speed laser physics will be honored this month for his pioneering work in biomedical optics by SPIE, the international society for optics and photonics.

7 Jan 2012

Research roundup: New ethics guidelines for doctors urge cost consideration; HIV testing in teens

Today's research comes from the Annals of Internal Medicine, the Journal of the American Medical Association, the Archives of Pediatrics and Adolescent Medicine, George Washington University and the Robert Wood Johnson Foundation.

7 Jan 2012

Study on benefits of Brain Wave Vibration meditation method

BEST Life Media, publisher of the Award Winning Brain Wave Vibration, and other books on health and wellness and the mind-body connection, is pleased to announce the results of a recent study concerning the Brain Wave Vibration meditation method.

7 Jan 2012

FDA approval of raltegravir offers new weapon to treat HIV infection in children

For children and adolescents with HIV infection, the recent Food and Drug Administration (FDA) approval of the use of raltegravir, an antiretroviral drug that slows the spread of HIV infection, offers a new weapon to treat HIV infection in children.

7 Jan 2012

SANUWAVE receives U.S. patent titled, 'Device for the Application of Acoustic Shock Waves'

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,088,073, titled "Device for the Application of Acoustic Shock Waves."

7 Jan 2012

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

7 Jan 2012

FDG-PET safe and accurate in detecting dementia, Alzheimer's

In a new review of imaging studies spanning more than ten years, scientists find that a method of positron emission tomography (PET) safely and accurately detects dementia, including the most common and devastating form among the elderly, Alzheimer's disease.

7 Jan 2012

Viewpoints: Sebelius on curbing the increase in health insurance costs; Forcing the mentally ill into treatment

The rising cost of health insurance coverage has imposed a heavy burden on our nation. Over the past decade, insurance premiums for working families have grown three times faster than have wages. Small businesses have seen health care become one of their biggest operating expenses. And rising state and federal spending on health programs has crowded out critical investments in better schools, new roads and other areas.

7 Jan 2012

Annual screening tests do not decrease deaths from prostate cancer

There's new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research led by Washington University School of Medicine in St. Louis.

6 Jan 2012

APUA applauds FDA for acting to limit antibiotics in food-producing animals

The Alliance for the Prudent Use of Antibiotics (APUA) today praised the U.S. Food and Drug Administration (FDA) for acting to limit certain extra label uses of cephalosporins in major animal species – cattle, swine, chickens and turkeys – where misuse and overuse are cause for great concern. Extra label use occurs when use of a drug does not comply with the approved labeling.

6 Jan 2012

Medicine News and Research

New Zealand life science and health IT companies to showcase their products in San Francisco

Proposal to tie likelihood of sleep apnea to body mass index

Winners of JHM competition to receive John G. Rangos Medal of Honor in Creative Thinking

OCF to offer free oral cancer screenings in April 2012

Major tobacco company manipulates data on effects of additives in cigarettes

Smokeless tobacco products in India associated with increased risk of oral cancer

CMS selects UofL geriatrician for Innovation Advisors Program

HHS Secretary Sebelius discusses agency's global health strategy at KFF/HHS briefing

Drinking red wine in moderation may reduce risk of breast cancer

Annual prostate cancer testing does not reduce mortality among men

SPIE to honor CCNY professor with Britton Chance Biomedical Optics Award

Research roundup: New ethics guidelines for doctors urge cost consideration; HIV testing in teens

Study on benefits of Brain Wave Vibration meditation method

FDA approval of raltegravir offers new weapon to treat HIV infection in children

SANUWAVE receives U.S. patent titled, 'Device for the Application of Acoustic Shock Waves'

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

FDG-PET safe and accurate in detecting dementia, Alzheimer's

Viewpoints: Sebelius on curbing the increase in health insurance costs; Forcing the mentally ill into treatment

Annual screening tests do not decrease deaths from prostate cancer

APUA applauds FDA for acting to limit antibiotics in food-producing animals

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News